BMY vs ROOT · P/E 17, rev $48.19B vs P/E 14, rev $1.18B
Bristol-Myers Squibb Company (BMY) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the BMY and ROOT stock pages for the full models.
Not investment advice.